SCHEMBL18800626

SCHEMBL18800626

COc1cccc(Oc2ccc(-c3cncc(N)c3C(=N)N)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ F2 P00734 2/20 0.45
▸ F10 P00742 2/20 0.45
▸ FURIN P09958 1/20 0.45
▸ BTK Q06187 1/20 0.45
▸ PRSS1 P07477 1/20 0.42
▸ PRSS2 P07478 1/20 0.42
▸ PRSS3 P35030 1/20 0.42
▸ MAPT P10636 5/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP11B1 P15538 2/20 0.41
▸ CYP11B2 P19099 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ FYN P06241 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800606 0.90 NQO2 (0.43) SMN1; SMN2F2BTKPRSS1PRSS2
SCHEMBL18800610 0.88 BTK (0.43) F2F10FURINBTKPRSS1
SCHEMBL18800738 0.87 TDO2 (0.49) SMN1; SMN2PRSS1PRSS2PRSS3MAPT
SCHEMBL18800557 0.86 PRSS1 (0.45) PRSS1PRSS2PRSS3MAPTCYP1A2
SCHEMBL18800739 0.81 MEN1 (0.39) F2F10BTKPRSS1PRSS2
SCHEMBL18800716 0.76 PRKCQ (0.37) SMN1; SMN2F2BTKPRSS1MAPT
SCHEMBL18800769 0.76 ADORA2A (0.48) SMN1; SMN2BTKMAPTTSHRNPC1
SCHEMBL18800867 0.75 BTK (0.50) F10BTKPRSS1PRSS2PRSS3
SCHEMBL18800614 0.74 ERBB2 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL18780264 0.73 BTK (0.55) BTKPRSS1FYNKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback